Classification of strokes in patients receiving intravitreal anti-vascular endothelial growth factor

Matthew R. Starr, Lauren A. Dalvin, Jackson E. AbouChehade, Gena M. Damento, Maria D. Garcia, Saumya M. Shah, David O. Hodge, Irene Meissner, Raymond Iezzi, Sophie J. Bakri

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

BACKGROUND AND OBJECTIVE: The purpose of this study was to identify the differences in the types of strokes seen in patients receiving intravitreal anti-vascular endothelial growth factor (VEGF) compared with normal control populations. PATIENTS AND METHODS: We performed a retrospective consecutive review of all patients receiving intravitreal anti-VEGF injections in Olmsted County, Minnesota, from January 1, 2004, to December 31, 2013, for exudative age-related macular degeneration (AMD), diabetic macular edema (DME), proliferative diabetic retinopathy (PDR), or retinal vein occlusion (RVO). A 2-year follow-up period was required for study inclusion. Three age- and sex-matched cohorts were identified. RESULTS: A total of 2,541 patients were examined. There were 690 patients identified during the study period as receiving an intravitreal injection for AMD, DME, PDR, or RVO. Of these patients, 38 (5.8%) suffered a stroke after starting intravitreal injection therapy. Of these strokes, 27 (71.1%) were ischemic, six (15.8%) were embolic, and five (13.2%) were hemorrhagic. There were no differences in the types of strokes identified among the patients receiving intravitreal injections between the case cohort and the control cohorts (P > .05 for all). CONCLUSION: The authors’ data suggest there is no predilection to the development of ischemic infarcts or hemorrhagic strokes in those patients receiving intravitreal anti-VEGF compared with control populations.

Original languageEnglish (US)
Pages (from-to)E140-E157
JournalOphthalmic Surgery Lasers and Imaging Retina
Volume50
Issue number5
DOIs
StatePublished - 2019

ASJC Scopus subject areas

  • Surgery
  • Ophthalmology

Fingerprint Dive into the research topics of 'Classification of strokes in patients receiving intravitreal anti-vascular endothelial growth factor'. Together they form a unique fingerprint.

Cite this